Penserra Capital Management LLC Ocular Therapeutix, Inc Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$6.16 - $12.07 $10,780 - $21,122	-1,750 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $145 - $215	15 Added 0.86%	1,750 $17,000
Q2 2021 Aug 12, 2021	BUY	$13.43 - $19.16 $470 - $670	35 Added 2.06%	1,735 $24,000
Q1 2021 May 13, 2021	BUY	$15.82 - $22.11 $949 - $1,326	60 Added 3.66%	1,700 $27,000
Q4 2020 Feb 12, 2021	BUY	$7.91 - $22.95 $12,972 - $37,638	1,640 New	1,640 $33,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.